This involves giving large doses of B12 injections, possibly every day or week, for a certain time
Randomization: AOD-9604 at doses 0.25, 0.5, 1.0 mg daily SC vs placebo
Chronic Inflammatory Conditions Many chronic conditions share an inflammatory component even when inflammation is not the primary feature
Cardiovascular risk2.4mg/wk The dose tested in the cardiovascular outcomes trial, which cut major adverse cardiovascular events by 20% in people with established cardiovascular disease and no diabetes
Experimental protocols should ensure the solution is completely utilized within a 30-day window to prevent baseline potency decay
Studied in models involving nicotinamide N-methyltransferase signaling, methylation-linked metabolism, and metabolic pathway regulation